AUNA's Peru Growth Highlights Regional Divergence, But Mexico Remains Key to Investment Case

What happened

A new article reports that AUNA's Peru operations are delivering double-digit revenue and EBITDA growth, driven by high-complexity care and expanded health plan reach. However, the DeepValue master report underscores that the company's investment thesis is critically dependent on Mexico's recovery from operational disruptions like IT system issues and physician alignment challenges. In the third quarter of 2025, Mexico revenue declined 12% year-over-year and adjusted EBITDA fell 29%, with leverage elevated at approximately 3.6 times net debt to EBITDA, highlighting persistent financial strain. The report maintains a 'WAIT' rating, indicating that upside requires Mexico to achieve year-over-year revenue growth and leverage improvement to below 3.3x by 2Q26, without dilutive equity financing. While Peru's performance is a positive development, it does not mitigate the central risks tied to Mexico's turnaround or the funding needs for the planned $500 million expansion, which could pressure the capital structure.

Implication

Peru's robust growth demonstrates operational execution in one market but does not resolve the core challenges in Mexico, where financial metrics are deteriorating and leverage remains high at ~3.6x net debt to EBITDA. The elevated leverage constrains financial flexibility and increases the risk of dilutive equity issuance, especially if the $500 million Mexico expansion is funded at depressed stock prices. Investors must monitor upcoming quarterly reports for signs of Mexico's revenue and EBITDA inflection, as per the DeepValue report's 90-day checkpoints, such as resolution of IT disruptions and measurable utilization improvements. Until clear progress is demonstrated in Mexico, the investment remains speculative, and entry should be based on operational milestones like YoY growth or a deeper discount below the attractive entry point of $4.60. The positive news from Peru is overshadowed by the need for capital structure clarity and Mexico's turnaround, which are essential for any re-rating.

Thesis delta

The article on Peru's gains does not shift the core investment thesis, which remains centered on Mexico's operational and financial recovery as the primary value driver. Peru's success provides a supportive tailwind but does not alter the key risks or catalysts, such as Mexico's need for YoY revenue growth and leverage improvement without dilution. The thesis will only change if Mexico shows sustained improvement in reported financials or if capital actions enhance per-share economics without exacerbating leverage.